Rhythm Metabolic's Series A - II Round

Rhythm Metabolic raised a round of funding on January 20, 2017.

Rhythm is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases and obesity, including obesity caused by genetic deficiencies in the MC4 pathw…

Articles about Rhythm Metabolic's Series A - II Round: